Dale Coffey, DO
Vascular Surgery · Wilmington, NCNPI 1477086767
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,049 of the $6,322 with a category attached, or 64.0%. 23 manufacturers reported payments, led by Medtronic at 48.6% of the total. 2025 is the largest year on record at $2,523, 4.7 times the $539 reported in 2022.
Across 71 payments — averaging $89.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- W. L. Gore & Associates, Inc.$748
- Boston Scientific$576
- Kerecis Limited$356
- Inari Medical, Inc.$304
- Silk Road Medical, Inc.$265
- plus $1K from 17 others
What the payments were for
- Travel & lodging$1,63726%
- Food & beverage$4,04964%
- Education$63610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 25 | $3,071 |
| W. L. Gore & Associates, Inc. | 6 | $748 |
| Boston Scientific | 12 | $576 |
| Kerecis Limited | 3 | $356 |
| Inari Medical, Inc. | 2 | $304 |
| Silk Road Medical, Inc. | 2 | $265 |
| Cardiovascular Systems Inc. | 1 | $137 |
| Abbott | 1 | $136 |
| Cook Medical LLC | 1 | $132 |
| Endologix LLC | 1 | $132 |
| Penumbra, Inc. | 2 | $129 |
| Shockwave Medical, Inc | 3 | $62 |
| Johnson & Johnson | 1 | $41 |
| Baxter Healthcare | 2 | $34 |
| Stryker | 1 | $32 |
| Bard Peripheral Vascular, Inc. | 1 | $29 |
| Terumo Medical Corporation | 1 | $26 |
| Smith+Nephew | 1 | $23 |
| Neuros Medical, Inc. | 1 | $21 |
| Davol Inc. | 1 | $20 |
| Artivion, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Solventum Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Valiant Captivia$1,393
- ENDURANT IIS$994
- Kerecis SurgiClose$791
- Kerecis Omega3 Marigen$481
- FLOWTRIEVER CATHETER, S$304
- CT THROMBECTOMY SYSTEM KIT$304
- GORE EXCLUDER AAA Endoprosthesis$253
- Kerecis GraftGuide$198
- GORE VIABAHN VBX Balloon Expandable Endo$190
- ENROUTE Transcarotid Stent$189
- ENROUTE Transcarotid Neuroprotection System$189
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$144
- GORE TAG Thoracic Branch Endoprosthesis$140
- Diamondback Peripheral$137
- SUPERA$136
- Zilver PTX$132
- Alto Abdominal Stent Graft System$132
- Kerecis Omega3 SurgiClose$120
How this compares
$6,322 in reported general payments places this provider in the 65th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $11,410 |
| ClopidogrelClopidogrel Bisulfate | 15 | $169 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $11,41012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 119 vascular surgery providers in North Carolina.
Other vascular surgery in Wilmington
- Thomas EskewWilmington$7K
- Frank ArkoCharlotte$2.6M
- Erin MurphyCharlotte$598K
- Robert MendesRaleigh$408K
- Ellen DillavouRaleigh$284K
- Mark FarberChapel Hill$245K
- Hector Crespo SotoCharlotte$178K
- Rebecca KelsoCharlotte$148K
- William MarstonChapel Hill$83K
- Bryan EhlertGoldsboro$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.